Showing posts with label
Cabaletta Bio Inc.
.
Show all posts
Showing posts with label
Cabaletta Bio Inc.
.
Show all posts
Wednesday, November 27, 2024
Cures for antoimmune diseases such as MD, Lupus, Mytosis MS and others are targets for this cutting edge, Bio Tech microcap!
›
Recent Developments, Nov 18th 2024 Cabaletta Bio, Inc. (Nasdaq: CABA) is a clinical-stage biotechnology company focused on developing engine...
›
Home
View web version
